Bangladesh claims to discover to COVID-19 vaccine by the pharmaceutical company, Globe Biotech Limited. This company confirms this news.
The World Health Organization (WHO) has listed the vaccine for pre-clinical trials of Globe Biotech Limited, a subsidiary of Bangladeshi pharmaceutical company Globe Pharmaceuticals Group of Companies Limited. Globe Biotech confirmed the information in a press release on Saturday (October 17). The list is also published on the WHO website.
“The World Health Organization (WHO) has listed three vaccines discovered by Globe Biotech Limited on October 15, 2020, as candidates for the Covid-19 vaccine,” the statement said. The three vaccine candidates here,
D614G variant mRNA vaccine
DNA Pietyid vaccine
Adenovirus Type-5 Vector Vaccine
“Bangladesh’s Globe Biotech is the only company in the world to have the top three vaccines on the list,” the statement said.
October 5, At a press conference, the CEO of Globe Biotech Ltd. Dr. Kakon Nagh informatated about their discovered vaccine name ‘BANCOVID’.
“The BANCOVID vaccine discovered in our own technology is the first and only discovered a vaccine against the D614G variant,” he said.
BANCOVID has already been shown to be completely safe and effective in animal model rat controlled and full pre-clinical trials. Detailed results of which have been published in pre-print format in the bio-archive (biorxiv.org).
According to Globe Biotech, all the sequences of Bangladeshi and international COVID-19 found in the NCBI virus database have been reviewed in detail through bioinformatics tools and their vaccination targets have been set. The company hopes the vaccine will be more effective worldwide.
“We have submitted the complete coding sequence of our ticker target to the NCBI database, which has already been published,” the organization said.
After a detailed analysis of the vaccine discovered in our laboratory, we have informed the world about the success of the vaccine research by initially obtaining satisfactory results in making appropriate antibodies by applying it to rabbits in laboratory animal models.
In an interview with the media on August 12, the head of the research and development department of Globe Biotech, Dr. Asif Mahmud said they are optimistic about bringing the coronavirus vaccine to the Bangladeshi market in December.
After a month of his optimism success, the World Health Organization (WHO) listed the vaccine for pre-clinical trials.
According to the NCBI virus database, 5,2867 complete genome sequences have been collected worldwide as of September 20. Of which 148 have been submitted from Bangladesh.
Globe Biotech Limited confirms their ticker target by testing the sequence through the Bioinformatics tool. Which would logically be more effective in this geographical area.
Meanwhile, Bangladeshi company Globe Biotech has expressed interest in conducting a clinical trial of a possible vaccine discovered in Nepal.
“As a doctor, I know the details of the vaccine called ‘BANCOVID’ made by Globe,” said the ambassador of Nepal Banshidhar Mishra. “For now, we are interested in getting this vaccine. If they succeed, we will be able to buy on a G2G basis. If the Bangladesh government agrees, Nepal is also interested in the clinical trial of this vaccine. ”
This was stated by the Ambassador of Nepal, Banshidhar Mishra at a press conference at the head office of Globe Pharmaceuticals in Tejgaon, Dhaka on October 21.